FDA.reportPublic FDA data

Farydak 15 MG Oral Capsule

RxCUI
1603365
RxNorm name
Farydak 15 MG Oral Capsule
Display name
Farydak 15 MG Oral Capsule
Full name
Farydak 15 MG Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:49

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
1b97bd3a-1040-4511-b0e6-4758e8083ae5FARYDAK 15 MG Oral Capsule [PSN] · panobinostat 15 MG Oral Capsule [Farydak] [SBD] · Farydak 15 MG Oral Capsule [SY]33These highlights do not include all the information needed to use FARYDAK safely and effectively. See full prescribing information for FARYDAK. FARYDAK ® (panobinostat) capsules, for oral use Initial U.S. Approval: 201520210727